Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedDec 21, 2024
DataAggregated Company Financials
Companies51
  • 7D-0.01%
  • 3M-10.1%
  • 1Y-2.7%
  • YTD-3.5%

The Pharma is pretty flat in the last 7 days, but Foresee Pharmaceuticals has stood out, gaining 3.3%. Unfortunately though, the industry is down 3.6% over the past 12 months. Earnings are forecast to grow by 63% annually.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Dec 2024NT$583.3bNT$109.3bNT$11.4b21.7x51x5.3x
Mon, 18 Nov 2024NT$620.1bNT$108.8bNT$10.1b23.6x61.7x5.7x
Wed, 16 Oct 2024NT$622.4bNT$104.7bNT$8.9b27.6x69.6x5.9x
Fri, 13 Sep 2024NT$635.4bNT$104.7bNT$8.9b25.4x71.1x6.1x
Sun, 11 Aug 2024NT$629.0bNT$101.2bNT$7.1b28.7x88.7x6.2x
Tue, 09 Jul 2024NT$711.4bNT$100.5bNT$6.8b32.7x104.2x7.1x
Thu, 06 Jun 2024NT$638.9bNT$100.4bNT$7.1b29.5x89.4x6.4x
Sat, 04 May 2024NT$619.1bNT$101.8bNT$9.4b24.9x66.2x6.1x
Mon, 01 Apr 2024NT$646.3bNT$101.2bNT$9.2b26.6x70.1x6.4x
Wed, 28 Feb 2024NT$658.2bNT$101.6bNT$8.2b24.6x80.2x6.5x
Fri, 26 Jan 2024NT$588.9bNT$101.9bNT$7.8b23.7x75.6x5.8x
Sun, 24 Dec 2023NT$580.6bNT$101.6bNT$7.6b23.4x76.1x5.7x
Tue, 21 Nov 2023NT$563.8bNT$101.8bNT$8.4b24.5x67.3x5.5x
Thu, 19 Oct 2023NT$520.3bNT$101.7bNT$9.6b20.1x54.1x5.1x
Sat, 16 Sep 2023NT$555.6bNT$101.7bNT$9.6b22.8x57.7x5.5x
Mon, 14 Aug 2023NT$556.9bNT$97.7bNT$7.9b19.9x70.1x5.7x
Wed, 12 Jul 2023NT$576.1bNT$98.7bNT$10.1b17x57.2x5.8x
Fri, 09 Jun 2023NT$578.5bNT$98.6bNT$10.1b16.8x57.5x5.9x
Sun, 07 May 2023NT$584.4bNT$92.1bNT$8.6b22.3x68.1x6.3x
Tue, 04 Apr 2023NT$569.0bNT$91.5bNT$8.7b20.7x65.8x6.2x
Thu, 02 Mar 2023NT$553.7bNT$84.7bNT$7.6b23.5x72.5x6.5x
Sat, 28 Jan 2023NT$484.3bNT$84.6bNT$7.9b20.6x61.4x5.7x
Mon, 26 Dec 2022NT$505.4bNT$84.6bNT$7.9b23.1x64.1x6x
Wed, 23 Nov 2022NT$452.9bNT$84.6bNT$7.7b16.2x58.8x5.4x
Fri, 21 Oct 2022NT$404.6bNT$78.9bNT$4.3b17x93.5x5.1x
Sun, 18 Sep 2022NT$459.4bNT$78.9bNT$4.3b18.4x106.2x5.8x
Tue, 16 Aug 2022NT$398.5bNT$79.0bNT$5.1b18.4x78.7x5x
Thu, 14 Jul 2022NT$379.8bNT$76.8bNT$4.4b21.4x86.9x4.9x
Sat, 11 Jun 2022NT$388.1bNT$76.8bNT$4.4b21.7x88.8x5.1x
Mon, 09 May 2022NT$385.4bNT$76.5bNT$6.4b21x60.2x5x
Wed, 06 Apr 2022NT$406.3bNT$76.4bNT$6.8b20.6x59.8x5.3x
Fri, 04 Mar 2022NT$407.9bNT$76.5bNT$8.7b20x46.7x5.3x
Sun, 30 Jan 2022NT$378.7bNT$76.7bNT$8.5b18.9x44.7x4.9x
Tue, 28 Dec 2021NT$386.6bNT$76.7bNT$8.5b18.2x45.7x5x
Price to Earnings Ratio

45.7x


Total Market Cap: NT$386.6bTotal Earnings: NT$8.5bTotal Revenue: NT$76.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 70.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 49.3x which is lower than its 3-year average PE of 70.4x.
  • The industry is trading close to its 3-year average PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 9.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-2.11%
Healthcare-1.31%
Pharma-0.011%
Pharma-0.011%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$603.006.5%
+NT$5.7b		207.7%PS1851.3x
6535 Lumosa TherapeuticsNT$196.505.1%
+NT$1.6b		193.3%PS856.9x
6620 Handa PharmaceuticalsNT$54.505.0%
+NT$367.1m		-72.2%PE17x
6576 Foresee PharmaceuticalsNT$75.903.0%
+NT$340.5m		-20.9%PS33.9x
4114 Synmosa BiopharmaNT$33.300.9%
+NT$126.1m		-6.4%PE19.5x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6620

NT$54.50

Handa Pharmaceuticals

7D

5.0%

1Y

-72.2%

1789

NT$21.60

ScinoPharm Taiwan

7D

-2.7%

1Y

-17.4%

4114

NT$33.30

Synmosa Biopharma

7D

0.9%

1Y

-6.4%

1760

NT$81.00

Panion & Bf Biotech

7D

-3.7%

1Y

-27.4%

4743

NT$86.20

Oneness Biotech

7D

-3.1%

1Y

-53.5%

4747

NT$71.60

Johnson Chemical Pharmaceutical Works

7D

2.0%

1Y

-14.5%

6785

NT$137.00

Alar Pharmaceuticals

7D

-6.2%

1Y

-34.4%

6576

NT$75.90

Foresee Pharmaceuticals

7D

3.0%

1Y

-20.9%

6919

NT$603.00

Caliway Biopharmaceuticals

7D

6.5%

1Y

207.7%

6535

NT$196.50

Lumosa Therapeutics

7D

5.1%

1Y

193.3%

6472

NT$737.00

Bora Pharmaceuticals

7D

-1.9%

1Y

14.8%

4123

NT$41.50

Center Laboratories

7D

-3.4%

1Y

-6.3%

4127

NT$41.50

Tien Liang BioTech

7D

4.3%

1Y

180.4%

1734

NT$29.60

Sinphar PharmaceuticalLtd

7D

1.4%

1Y

-5.6%

1720

NT$61.10

Standard Chemical & Pharmaceutical

7D

-3.0%

1Y

-6.1%

3716

NT$35.60

Cenra

7D

-3.8%

1Y

n/a